Instylla First-In-Human Clinical Trial Published Results
Instylla notes prospective multicenter study evaluated the safety and efficacy of a PEG-based liquid embolic in treating hypervascular tumors.
Request Advertising / Posting Opportunities
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm
Florida / New York
Phone: 561.316.3330